Israeli Company Cannabics Pharmaceuticals Looking To Raise $US4 Million

A little off topic but interesting to note where they see their market

Cannabics Pharmaceuticals estimates that the medical marijuana market has the potential to reach $3.6 million in the US alone, the Globes newspaper reported Monday.

Reports the Times of Israel

The company, whose share price has fallen along with the rest of the sector since peaking in 2014, is currently presenting its wares to Israeli, American and European investors as part of a bid to raise $4 million through a private placement, the newspaper said. The offering, made privately to selected investors, is expected to close next month.

Cannabics’ cannabis-oil pill is on sale in Israel and in Colorado in the US. Now, the company is developing a system for using a cannabis ingredient to help doctors evaluate biopsies more accurately.

The $4 million is needed to commercialize the evaluation system and to perform a clinical trial on 40 cancer patients at Rambam Medical Center in Haifa, northern Israel.

Cannabics — a US-based company founded by Israeli researchers in molecular biology and cancer — carries out its research and development in Israel in collaboration with Israeli medical centers.

It expects to be turning a profit by late 2017 and predicts sales of $84 million in 2019.

Cannabis Law Report Has Been Publishing Legal, Professional & Regulated
Cannabis News Daily Since 2016 – All For Free

We want to carry on providing the important cannabis sector
news for free for all our readers.

Costs are rising to produce Cannabis Law Report and we’d like to ask you,
our readers, for a small donation.

Primary Sponsor

New: Free USA Cannabis Case Law Search – New Cases Daily

Directory Categories

Sponsor – aBizinaBox

Top Marijuana Blog
%d bloggers like this: